Aditya Birla Sun Life Pharma and Healthcare Fund
In plain words
as of 20 Nov 2026Over 5 years it returned 16.2% a year, above the middle Sectoral / Thematic fund (13.4%) by 2.8 points.
Trailed its benchmark by 0.7 points a year over 5 years (16.2% vs 16.9%).
Its ups and downs have been smaller than most funds in its category. Volatility 14.6% vs a category middle of 17.4%.
The deepest fall was −20.5% (Sep 2021 to Jun 2022); it recovered in 398 days.
Of every 1-year period since launch, 19% ended below where they started. The middle 1-year result was 18.0%.
Key facts
- Fund house
- Aditya Birla Sun Life Mutual Fund
- Category
- Sectoral / Thematic (SEBI)
- Plan & option
- Direct · Growth
- Benchmark i
- NIFTY Pharma TRI (tracked via Nippon India Nifty Pharma ETF - Direct Plan)
- First NAV
- 11 Jul 2019 · 7.4 years of history · 1,813 NAVs
- AMFI code
- 147409
- ISIN
- INF209KB1O25
- Expense ratio i
- 1.04%
- Fund size
- Not loaded yet
How ₹100 grew
Returns
Up to 1 year: total change. Longer: yearly (CAGR) i| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 7Y | 10Y | Since launch | |
|---|---|---|---|---|---|---|---|---|---|---|
| This fund | +10.45% | +2.06% | +11.10% | +22.61% | +21.04% | +20.35% | +16.19% | +21.44% | — | +21.24% |
| NIFTY Pharma TRI* | +10.85% | +7.49% | +14.67% | +25.66% | +25.86% | +22.31% | +16.87% | — | — | — |
| Sectoral / Thematic middle fund i | +7.16% | +0.76% | +8.62% | +4.78% | +4.45% | +14.50% | +13.44% | +17.71% | +15.62% | — |
Category middle = median Direct Growth fund in Sectoral / Thematic (145 funds with 3 years). * Benchmark approximated by Nippon India Nifty Pharma ETF - Direct Plan with its expense ratio added back. Blank means not enough history, never zero.
Risk and risk-adjusted return
Last 36 months · risk-free rate 6.5%Against its benchmark
NIFTY Pharma TRI · 36 monthly returnsThe worst it has been
Every 1-year period i
One 5-year number depends on its start date. These show what happened across every start date in the fund's life.
What it holds
Against similar funds
Top Sectoral / Thematic Direct Growth funds by return. A sort by one past number, not a recommendation.
| Fund | Return | Volatility | Sharpe | Alpha | Beta | Deepest fall | Stars |
|---|---|---|---|---|---|---|---|
| HDFC Defence Fund HDFC | +31.36% | 30.9% | 0.80 | — | — | −34.54% | ★★★★★ |
| Nippon India Taiwan Equity Fund Nippon India | +31.07% | 42.4% | 0.58 | +30.90% | −0.14 | −47.10% | ★★★★★ |
| HDFC Pharma and Healthcare Fund HDFC | +30.70% | 15.8% | 1.53 | +7.32% | 0.97 | −14.91% | ★★★★★ |
| SBI HEALTHCARE OPPORTUNITIES FUND SBI | +24.78% | 14.1% | 1.30 | +5.05% | 0.86 | −30.53% | ★★★★★ |
| HDFC Transportation and Logistics Fund HDFC | +24.43% | 19.1% | 0.94 | +10.99% | 1.02 | −23.50% | ★★★★★ |
| Mirae Asset Healthcare Fund Mirae Asset | +24.02% | 15.5% | 1.13 | +3.14% | 0.96 | −19.98% | ★★★★★ |
| UTI - Healthcare Fund UTI | +23.24% | 15.4% | 1.09 | +2.96% | 0.91 | −27.10% | ★★★★★ |
| Aditya Birla Sun Life Transportation and Logistics Fund ABSL | +23.16% | 19.9% | 0.84 | +9.40% | 1.09 | −28.25% | Not rated |
| ICICI PRUDENTIAL TRANSPORTATION AND LOGISTICS FUND ICICI Pru | +22.67% | 18.9% | 0.86 | +9.10% | 1.06 | −23.58% | ★★★★★ |
| LIC MF Healthcare Fund LIC | +21.83% | 15.5% | 0.99 | +2.12% | 0.90 | −15.10% | ★★★★★ |
| Aditya Birla Sun Life Pharma and Healthcare Fund ABSL | +20.35% | 14.6% | 0.95 | −0.72% | 0.94 | −20.46% | ★★★★★ |
Compare side by side with another Sectoral / Thematic fund
If you had run a SIP i
₹10,000 on the first NAV of every month for 5 years: ₹6,00,000 invested would be worth ₹9,93,026 on 20 Nov 2026.
XIRR counts each instalment for the time it was invested, so it is the return a SIP investor actually got.
Try your own amount and datesAll plans and options
| Scheme | NAV | AMFI code |
|---|---|---|
| Direct · Growth | ₹41.5400 | 147409 |
| Direct · IDCW | ₹27.0100 | 147410 |
| Regular · Growth | ₹37.1800 | 147407 |
| Regular · IDCW | ₹24.5500 | 147408 |
About Sectoral / Thematic funds
- The rule
- At least 80% in one sector (banking, pharma, IT ...) or theme (consumption, manufacturing ...).
- Who it can suit
- Investors adding a deliberate bet on top of a diversified core.
- Typical holding period
- 7 years or more
Questions people ask
What is the NAV of Aditya Birla Sun Life Pharma and Healthcare Fund?
₹41.5400 as of 20 Nov 2026, from AMFI's daily NAV file. NAVs are published once every business day after markets close.
Direct or Regular: what is the difference?
Same portfolio. Regular pays a distributor commission inside its fee, so it returns a little less every year.
Growth or IDCW?
Growth reinvests everything. IDCW pays some out, so its NAV drops after each payout and its NAV-based return understates what investors received.
How are these numbers calculated?
Every figure is computed by Growth from the fund's published NAV history. See How we calculate.